Drug for further processing · DRUG FOR FURTHER PROCESSING
Topiramate NDC 0480-2359
Topiramate 200 mg/1 · Capsule, Extended release · Teva Pharmaceuticals, Inc.
Unfinished product
This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0480-2359-99 | 00480235999 | 7800 CAPSULE, EXTENDED RELEASE in 1 CONTAINER (0480-2359-99)Marketed from 10-MAR-23 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Generic name (nonproprietary)
- topiramate
- Active ingredients
- Topiramate — 200 mg/1
- Dosage form
- Capsule, Extended release
- Labeler
- Teva Pharmaceuticals, Inc.NDC labeler code 0480
- Product type
- Drug for further processing
- Marketing category
- Drug for further processing
- Marketing start
- Listing expires
- Identifiers
- Product ID 0480-2359_b0cdf274-d60e-4b12-a4f7-eb15b6d9fd9fSPL ID b0cdf274-d60e-4b12-a4f7-eb15b6d9fd9f
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400480235999followed by a unit qualifier and the quantityPackage 00480-2359-99. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0480-2359
- What is NDC 0480-2359?
- 0480-2359 is the product NDC for Topiramate, Topiramate 200 mg/1 capsule, extended release, listed with the FDA by Teva Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Topiramate.
- What is the active ingredient?
- Topiramate.
- Who is the labeler?
- Teva Pharmaceuticals, Inc., NDC labeler code 0480. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Topiramate?
- 278 other product NDCs are listed under this name. See all Topiramate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Topiramate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| topiramate | Topiramate 50 mg/1 | Tablet, Film coatedOral | St. Mary's Medical Park Pharmacy | 60760-952 | 60760-0952-60 |
| topiramate | Topiramate 100 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-0357 | 67046-0357-03 |
| topiramate | Topiramate 100 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-1691 | 67046-1691-03 |
| Topiramate | Topiramate 25 mg/1 | Tablet, Film coatedOral | Unit Dose Solutions, Inc. | 87441-079 | 87441-0079-01 |
| Topiramate | Topiramate 100 mg/1 | TabletOral | Coupler LLC | 67046-1688 | 67046-1688-03 |
| topiramate | Topiramate 25 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-0375 | 67046-0375-03 |
| topiramate | Topiramate 200 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-809 | 50268-0809-15 |
| topiramate | Topiramate 25 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-806 | 50268-0806-15 |
| topiramate | Topiramate 50 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-807 | 50268-0807-15 |
| topiramate | Topiramate 100 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-808 | 50268-0808-15 |